NEUROPEPTIDE Y (13-36) (HUMAN, RAT)
NEUROPEPTIDE Y (13-36) (HUMAN, RAT)
NEUROPEPTIDE Y (13-36) (HUMAN, RAT) 性质
| 密度 | 1.49±0.1 g/cm3(Predicted) |
|---|---|
| 储存条件 | -15°C |
| 溶解度 | 溶于二甲基亚砜 |
| 形态 | 固体 |
| 颜色 | 白色至米白色 |
| 序列 | Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 |
NEUROPEPTIDE Y (13-36) (HUMAN, RAT) 用途与合成方法
|
NPYY 2 receptor
|
Neuropeptide Y (13-36) (intraventricular injection; 25-3000 pmol) produces a dose-dependent increase (up to 14%; ED 50 value of 0.3 nmol for overall effects and 0.97 nmol for the peak effects) in mean arterial blood pressure in the awake, unrestrained male rat without affecting heart rate. Central administration of porcine Neuropeptide Y (13-36) produces marked vasodepressor and bradycardic actions in the anaesthetized α-chloralose and in the awake unrestrained male rat.Neuropeptide Y (13-36) (intracerebroventricular injection; 50 ng; alone; injected 30 and 15 min before measurements) injected into naïve mice impairs social novelty preference, but not sociability, and this effect is inhibited by the NPY Y 2 receptor antagonist BIIE 0246.
| Animal Model: | Male ICR mice (age 4-7 weeks) |
| Dosage: | 50 ng/mouse |
| Administration: | Intracerebroventricular injection |
| Result: | Significantly decreased interaction time with the new stranger mouse in session 3 that NPY 13-36. |
NEUROPEPTIDE Y (13-36) (HUMAN, RAT) 价格(试剂级)
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2026-06-05 | HY-P1480 | NEUROPEPTIDE Y (13-36) (HUMAN, RAT) | 122341-40-6 | 1mg | 1100 |
| 2026-06-05 | HY-P1480 | NEUROPEPTIDE Y (13-36) (HUMAN, RAT) | 122341-40-6 | 5mg | 3200 |
